Article thumbnail

Carcinomatous Meningitis: The Natural History of Successfully Treated Metastatic Bladder Cancer

By S. Tadepalli, T. Coleman, L.A. Hacket and G.B. Liles


Carcinomatous meningitis due to bladder cancer is a rare entity reported only in case reports. Optimal therapy is thus poorly defined with earlier cases reporting an unsuccessful outcome. Here we report a case of late carcinomatous meningitis secondary to transitional cell carcinoma (TCC) of the bladder occurring in a patient in complete remission. He was successfully treated with intrathecal methotrexate and whole brain irradiation and experienced prolonged survival after treatment. With modern chemotherapy increasing complete remissions and survival rates in patients with TCC, more and more patients are being reported with carcinomatous meningitis. We raise the question of whether central nervous system prophylaxis should be considered in patients with TCC achieving a complete remission to chemotherapy in the metastatic setting

Topics: Published: August 2011
Publisher: S. Karger AG
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1987). A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.
  2. (1992). A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
  3. (2000). al: Carcinomatosis meníngea como primera manifestación del carcinoma de vejiga: a propósito de dos casos. An Med Interna
  4. al: Carcinomatous meningitis from primary signet ring cell carcinoma of bladder.
  5. (1995). al: Carcinomatous meningitis from transitional cell carcinoma of bladder. Urology
  6. al: Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature.
  7. al: Carcinomatous meningitis secondary to transitional cell bladder cancer.
  8. al: Isolated meningeal recurrence of transitional cell carcinoma of the bladder. Case Rep Oncol 2010;3:171–175.
  9. al: Leptomeningeal carcinomatosis from urinary bladder adenocarcinoma: a clinicopathological case study.
  10. (1993). al: Meningeal carcinomatosis from transitional cell carcinoma of the bladder.
  11. al: Meningeal carcinomatosis: an extremely rare involvement of urinary bladder carcinoma.
  12. al: Neurologic complications of bladder carcinoma: a review of 359 cases.
  13. (1985). al: Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
  14. al: Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis.
  15. (1997). al: Solitary meningeal recurrence in a patient with transitional cell carcinoma of the bladder with locally bulky disease at presentation.
  16. (1990). al: Transitional cell carcinomatous meningitis after M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) chemotherapy. Urology
  17. (1975). BM: Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
  18. Carcinomatous meningitis from transitional cell carcinoma of the bladder: case report.
  19. (2004). Carcinomatous meningitis from urothelial carcinoma of bladder and ureter: case report. Nippon Hinyokika Gakkai Zasshi
  20. Cerebrospinal fluid and metastasis of transitional cell carcinoma of the bladder.
  21. (1991). Chye RWM: Treatment of carcinomatous meningitis from transitional cell carcinoma of the bladder.
  22. (1998). Current diagnosis and treatment of leptomeningeal metastasis.
  23. (1993). DM: Complex partial status epilepticus in a patient with dural metastases.
  24. (2010). et al: Cancer statistics,
  25. et al: Carcinomatosis meníngea en un tumor vesical. Actas Urol Esp
  26. (1998). et al: High incidence of brain metastases in patients treated with an M-VAC regimen for advanced bladder cancer. Eur Urol
  27. (1999). et al: Meningeal carcinomatosis from transitional cell carcinoma of the bladder: report of two cases and review of the literature. Cancer Invest
  28. (2002). et al: Sudden bilateral hearing loss disclosing meningeal carcinomatosis. Rev Neurol
  29. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.
  30. (1997). Imamura S: Clinicopathologic study of leptomeningeal carcinomatosis involving the temporal bone. Ann Otol Rhinol Laryngol
  31. Isolated hypoglycorrachia: leptomeningeal carcinomatosis causing subacute confusion.
  32. (1997). La méningite carcinomateuse: une complication rare du cancer de la vessie. Rev Méd Interne
  33. Meningeal carcinomatosis as the first manifestation of a transitional cell carcinoma of the bladder.
  34. T: A novel method for administering intrathecal chemotherapy in patients with leptomeningeal metastases and shunted hydrocephalus: case report.
  35. (1987). Walzak MP: Brain metastases from transitional cell carcinoma.